首页 | 本学科首页   官方微博 | 高级检索  
     


Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy
Authors:Yasuhiro Mitsui  Yasushi Sato  Hiroshi Miyamoto  Yasuteru Fujino  Toshi Takaoka  Jinsei Miyoshi  Miwako Kagawa  Hiroyuki Ohnuma  Masahiro Hirakawa  Tomohiro Kubo  Takahiro Osuga  Tamotsu Sagawa  Yasuhiro Sato  Yasuo Takahashi  Shinich Katsuki  Toshinori Okuda  Rishu Takimoto  Masayoshi Kobune  Takayuki Nobuoka  Koichi Hirata  Junji Kato  Tetsuji Takayama
Affiliation:1. Department of Gastroenterology and Oncology, Institute of Health Biosciences, University of Tokushima Graduate School, 3-18-15, Kuramoto-cho, Tokushima City, 770-8503, Japan
2. Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo, 060-8543, Japan
3. Division of Gastroenterology, Hokkaido Cancer Center, 4-2-3-54, Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan
4. Division of Gastroenterology, Otaru Ekisaikai Hospital, 1-10-17, Shikinai, Otaru, 047-0031, Japan
5. Department of Gastroenterology, Oji General Hospital, 3-4-8, Wakakusa-cho, Tomakomai, 053-0021, Japan
6. Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo, 060-8543, Japan
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号